Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study.
Leukemia. 2020 Aug;34(8):2125-2137. doi: 10.1038/s41375-020-0915-9. Epub 2020 Jun 22.
Leukemia. 2020.
PMID: 32572189
Free PMC article.
Clinical Trial.
Efficacy of non-intensive therapies approved for relapsed/refractory acute myeloid leukemia: a systematic literature review.
Russell-Smith TA, Gurskyte L, Muresan B, Mamolo CM, Gezin A, Cappelleri JC, Heeg B.
Russell-Smith TA, et al.
Future Oncol. 2022 May;18(16):2029-2039. doi: 10.2217/fon-2021-1355. Epub 2022 Feb 24.
Future Oncol. 2022.
PMID: 35196866
Free article.
Review.
Item in Clipboard
Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UK.
Russell-Smith TA, Brockbank J, Mamolo C, Knight C.
Russell-Smith TA, et al.
Pharmacoecon Open. 2021 Dec;5(4):677-691. doi: 10.1007/s41669-021-00278-3. Epub 2021 Jun 28.
Pharmacoecon Open. 2021.
PMID: 34181204
Free PMC article.
Item in Clipboard
Cost-Effectiveness of Inotuzumab Ozogamicin Compared to Standard of Care Chemotherapy for Treating Relapsed or Refractory Acute Lymphoblastic Leukaemia Patients in Norway and Sweden.
van Oostrum I, Russell-Smith TA, Jakobsson M, Torup Østby J, Heeg B.
van Oostrum I, et al. Among authors: russell smith ta.
Pharmacoecon Open. 2022 Jan;6(1):47-62. doi: 10.1007/s41669-021-00287-2. Epub 2021 Jul 26.
Pharmacoecon Open. 2022.
PMID: 34309818
Free PMC article.
Item in Clipboard
Systematic review and pooled analysis of survival outcomes in patients with relapsed or refractory B-cell acute lymphoblastic leukaemia who have undergone haematopoietic stem cell transplant.
Russell-Smith TA, Chadda S, LeReun C, Bajko P, Doogan E.
Russell-Smith TA, et al.
Eur Rev Med Pharmacol Sci. 2022 Feb;26(3):975-995. doi: 10.26355/eurrev_202202_28007.
Eur Rev Med Pharmacol Sci. 2022.
PMID: 35179764
Free article.
Item in Clipboard
The Zero-Price Conundrum: Exploration of Scenarios Where a Clinically Effective New Drug Might Not Be Cost-Effective at Zero Price.
Mladsi D, Barnett CL, Mader G, Russell-Smith TA, Unuigbe A, Bell T.
Mladsi D, et al. Among authors: russell smith ta.
Value Health. 2023 Mar;26(3):384-391. doi: 10.1016/j.jval.2023.01.004. Epub 2023 Jan 24.
Value Health. 2023.
PMID: 36706950
Free article.
Item in Clipboard
Cite
Cite